Author

A. Ravindra

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Clinical and genomic characterization of KRAS G13X non-small cell lung carcinoma

KRAS G13X mutations represent a small but clinically meaningful subset of NSCLC defined by a distinctive co-mutation pattern and Combinational therapeutic strategies addressing these vulnerabilities can help improve outcomes.

Benjamin J. Staum, Rachaita Lakra, A. Ravindra et al. · Frontiers in Oncology · 0 citations

Open access Sep 2026

Anthracycline-containing versus anthracycline-free carboplatin-based regimens in early-stage triple-negative breast cancer: real-world outcomes

Triple‑negative breast cancer (TNBC) is an aggressive disease with poor survival outcomes. With the integration of immunotherapy, the optimal neoadjuvant chemotherapy backbone remains poorly defined. We examined real-world treatment patterns and response rates among patients receiving a carboplatin-based regimen, with...

Matthew R. Kroll, Mary C. Schroeder, J. M. Neuner et al. · Breast Cancer Research and T... · 0 citations